About Vivelle-Dot Transdermal ET

Tell a friend about Vivelle-Dot.
A Patch So Small You’ll Hardly Notice It

Vivelle-Dot is offered in a range of dosage strengths 1. It’s an estrogen-only treatment for women who don’t have a uterus. If you still have your uterus, ask your doctor about CombiPatch® (estradiol/norethindrone acetate transdermal system) for the treatment of moderate to severe menopausal symptoms.2 Or ask your doctor about progestins that can be taken with Vivelle-Dot. And did we mention that Vivelle-Dot is the smallest estrogen therapy (ET) patch available?

Vivelle-Dot Provides:

  • Proven relief of moderate to severe menopausal symptoms1 and prevention of postmenopausal osteoporosis
  • The smallest, most discreet estrogen patch available
  • Smaller total doses than pills. Patches achieve effective hormone levels with smaller doses compared to pills. This does not mean that patches are safer or more effective
  • Convenient dosing — twice a week
  • For women interested in the source of estrogen in their therapy, the estrogen in Vivelle-Dot (estradiol) is chemically synthesized from a plant source. This does not mean Vivelle-Dot is safer or more effective.

Small Size and Wearability Are Strengths of Vivelle-Dot

Vivelle-Dot is the smallest ET patch available today. The 0.05 mg/day patch is the size of a standard postage stamp.

Vivelle-Dot is designed to feel natural, to go where you go — even in the swimming pool — without coming off.

See for yourself how the Vivelle-Dot patch looks and feels. Request a Vivelle-Dot non-medicated sample to try. And it's free!



Advanced System for Estrogen Delivery

Vivelle-Dot was created using the patented DOT Matrix delivery system. DOT Matrix technology allows Vivelle-Dot to be the smallest ET patch available capable of maintaining predictable and effective estrogen delivery for the relief of moderate to severe menopausal symptoms1 and the prevention of postmenopausal osteoporosis. For women interested in the source of estrogen in their therapy, the estrogen in Vivelle-Dot is chemically synthesized from a plant source. This does not mean that Vivelle-Dot is safer or more effective than other hormone therapies.

Vivelle-Dot: A Skin-Friendly Patch

Vivelle-Dot has been shown to have a low incidence of skin irritation.

Quick, Easy Dosing

Women need only apply the Vivelle-Dot patch twice a week for proper dosing and effective relief of their moderate to severe menopausal symptoms1 and prevention of postmenopausal osteoporosis.

Thin and Translucent

Vivelle-Dot is a tiny, thin translucent patch. Women apply the inconspicuous patch on the skin of the lower abdomen.

Most Common Side Effects

As with any medication, side effects can occur. The most common side effects with Vivelle-Dot are headache, breast tenderness and back pain.

DOT Matrix is a registered trademark of Noven Pharmaceuticals, Inc.

The information contained within this Web site is appropriate for U.S. residents only. A visit to this site should not replace a visit to your doctor.

Available by prescription only.

*IMS Health® National Prescription Audit Plus, 2/2006

Copyright © 2008 Novogyne Pharmaceuticals. All rights reserved.

Vivelle-Dot Home Page About Menopause Living With Menopause About Estrogen Therapy About Vivelle-Dot Prescribing Information
For Healthcare Professionals Contact Us
About Novogyne Glossary Site Map Privacy Policy Terms of Use